Effectiveness over time of a primary series of the original monovalent COVID-19 vaccines in adults in the United States.
Saved in:
| Title: | Effectiveness over time of a primary series of the original monovalent COVID-19 vaccines in adults in the United States. |
|---|---|
| Authors: | Layton JB; RTI Health Solutions, Research Triangle Park, North Carolina, United States of America., Lloyd PC; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America., Peetluk LS; Optum Epidemiology, Boston, Massachusetts, United States of America., Jiao Y; Acumen LLC, Burlingame, California, United States of America., Djibo DA; Safety Surveillance & Collaboration, CVS Health, Blue Bell, Pennsylvania, United States of America., Gruber JF; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America., Deng J; Optum Epidemiology, Boston, Massachusetts, United States of America., Bui C; RTI Health Solutions, Research Triangle Park, North Carolina, United States of America., Lo AC; Acumen LLC, Burlingame, California, United States of America., Ogilvie RP; Optum Epidemiology, Boston, Massachusetts, United States of America., Parambi R; Optum Epidemiology, Boston, Massachusetts, United States of America., Miller M; Optum Epidemiology, Boston, Massachusetts, United States of America., Song J; Optum Epidemiology, Boston, Massachusetts, United States of America., Weatherby LB; Optum Epidemiology, Boston, Massachusetts, United States of America., Cho S; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America., Wong HL; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America., Clarke TC; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America., Hervol JR; Acumen LLC, Burlingame, California, United States of America., Illei D; RTI International, Washington, District of Columbia, United States of America., Bell EJ; Optum Epidemiology, Boston, Massachusetts, United States of America., Yang GW; OptumServe, Falls Church, Virginia, United States of America., Seeger JD; Optum Epidemiology, Boston, Massachusetts, United States of America., Wernecke M; Acumen LLC, Burlingame, California, United States of America., Richey MM; RTI Health Solutions, Research Triangle Park, North Carolina, United States of America., Forshee RA; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America., Anderson SA; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America., Chillarige Y; Acumen LLC, Burlingame, California, United States of America., McMahill-Walraven CN; Safety Surveillance & Collaboration, CVS Health, Blue Bell, Pennsylvania, United States of America., Amend KL; Optum Epidemiology, Boston, Massachusetts, United States of America., Anthony MS; RTI Health Solutions, Research Triangle Park, North Carolina, United States of America., Shoaibi A; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America. |
| Source: | PloS one [PLoS One] 2025 May 06; Vol. 20 (5), pp. e0320434. Date of Electronic Publication: 2025 May 06 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
